Temoglan Infusion
Marketer
Gland Pharma Limited
Salt Composition
Temozolomide (NA)
Overview Temoglan Infusion
Brain cancer recurrence or progression following standard therapies is treated with Temoglan Infusion. This medication may also be prescribed for other conditions under a physician's direction. Administration is solely by a healthcare professional; self-administration is strictly prohibited. Dosage and frequency are determined by your doctor based on your condition's severity and may be adjusted. Therapeutic effects might not be immediately apparent, potentially taking weeks or months; discontinue only as directed by your physician. Common side effects encompass nausea, vomiting, constipation, headaches, and tiredness. A decreased blood cell count, increasing infection risk, is a possibility; regular blood tests monitoring blood cell levels, kidney, liver, and heart function are mandatory. Prior to commencing treatment, disclose any bleeding disorders, hepatic or renal impairment, or current infection-related medications. Potential interactions with other medications necessitate informing your doctor of all medications you're taking. Pregnancy and breastfeeding contraindicate Temoglan use; reliable contraception for both partners is crucial throughout treatment.
Uses of Temoglan Infusion
Neoplasm of the cerebrum
Major Benefits of Temoglan Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Temoglan Infusion:
- Memory loss
- Rash
- Headache
- Dizziness
- Convulsion
- Coordination disorder
- Insomnia (difficulty in sleeping)
- Vomiting
- Weakness
- Nausea
- Loss of appetite
- Hair loss
- Fatigue
- Fever
- Diarrhea
- Constipation
- Hemiparesis (weakness on one side of the body)
- Viral infection
How to use Temoglan Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Temoglan Infusion works:
Temoglan Infusion is a cancer treatment that penetrates brain tissue. Its mechanism of action involves disrupting the genetic makeup (DNA and RNA) of cancerous cells, thereby halting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Temoglan Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Temoglan Infusion during pregnancy poses a confirmed risk to the fetus and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Breastfeeding is contraindicated during Temoglan Infusion therapy. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Temoglan Infusion may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is strongly discouraged if these effects manifest.
KidneySAFE IF PRESCRIBED
Temoglan Infusion appears to pose minimal risk for individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary for such patients. However, physician consultation is recommended. Exercise caution when administering Temoglan Infusion to patients exhibiting severe kidney dysfunction.
LiverCAUTION
For patients exhibiting severe hepatic impairment, Temoglan Infusion requires careful administration and potential dosage modification. Limited data exists regarding its use in such cases. Consult a physician for guidance. Dosage alteration isn't typically advised for individuals with mild or moderate liver dysfunction.
What if you forget to take Temoglan Infusion :
Should you forget a Temoglan Infusion dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Temoglan Infusion
| Label | Value |
|---|---|
| Chemical Type | Dacarbazine Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Active Class | Alkylating substance |
3,018 People bought this recently